(Q34431577)

2 August 2017

1 reference

title

Effect of immunostimulatory CpG-oligonucleotides in chronic lymphocytic leukemia B cells (English)

1 reference

chronic lymphocytic leukemia

2 August 2017

0 references

1 reference

1 reference

Decker T

1

1 reference

PubMed ID

11699394

2 August 2017

Peschel C

series ordinal

2

1 reference

2 August 2017

1 July 2001

1 reference

2 August 2017

1 reference

2 August 2017

42

1 reference

2 August 2017

3

1 reference

2 August 2017

301-307

1 reference

CpG motifs in bacterial DNA trigger direct B-cell activation

2 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Immune activation by bacterial DNA: a new genetic code

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

The instructive role of innate immunity in the acquired immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Toll signaling pathways in the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

The role of cell surface receptors in the activation of human B cells by phosphorothioate oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Activation of human B cells by phosphorothioate oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Type I interferon-mediated stimulation of T cells by CpG DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Bacterial DNA as immune cell activator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

The role of CpG in DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Clinical trials of antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Redefining the therapeutic goals in chronic lymphocytic leukemia: towards an evidence-based, risk-adapted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Levels of expression of CD19 and CD20 in chronic B cell leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Anticancer drug targets: cell cycle and checkpoint control.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

Bacterial DNA causes septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109064586

10.3109/10428190109064586

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11699394